Wang-Zheng Berhad (KLSE:WANGZNG)

Aerovate Therapeutics Revenue

Wang-Zheng Berhad had revenue of 80.04M MYR in the quarter ending March 31, 2025, with 15.22% growth. This brings the company's revenue in the last twelve months to 319.33M, up 15.38% year-over-year. In the year 2024, Wang-Zheng Berhad had annual revenue of 308.76M with 9.33% growth.

• Revenue (ttm): 319.33M
• Revenue Growth: +15.38%
• P/S Ratio: 0.20
• Revenue / Employee: 712.79K
• Employees: 448
• Market Cap: 63.26M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	308.76M	26.35M	9.33%
Dec 31, 2023	282.41M	14.12M	5.26%
Dec 31, 2022	268.29M	43.00M	19.09%
Dec 31, 2021	225.29M	-17.36M	-7.16%
Dec 31, 2020	242.65M	-30.86M	-11.28%